LWT-16665-34780
3 vaccinations
2 coded responses
36 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 234 / VA
- Registered
- 2021-01-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-06
Registered in v-safe
-
2021-01-06
Dose 1 — Pfizer-BioNTech
-
2021-01-06
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-07
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-01-08
- 2021-01-09
- 2021-01-10
- 2021-01-15
- 2021-01-21
-
2021-01-27
Dose 2 — Pfizer-BioNTech
- 2021-01-27
-
2021-01-28
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-29
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Muscle or body achesAdult check-in
-
2021-01-30
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-01-31
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Rash, not including the immediate area around the injection siteAdult check-in
- 2021-02-02
- 2021-02-03
- 2021-02-10
- 2021-02-17
- 2021-02-24
- 2021-03-03
- 2021-03-10
- 2021-04-28
- 2021-07-28
-
2022-01-27
Survey response — 12 months, dose 2MedDRA: Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
-
2022-01-27
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-02-01
-
2022-10-27
Dose 3 — Moderna
-
2022-10-28
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-10-29
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness · Headache, Fatigue or tirednessAdult check-in
-
2022-10-30
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-10-31
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-11-01
-
2022-11-02
Health check-in — days 1–6 daily, dose 3Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-11-03
Health check-in — day 7, dose 3Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-11-10
Survey response — day 14, dose 3MedDRA: Pre-existing disease, Rash, Rash erythematous, Rash pruritic — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Flare in skin rashes. Redness and itchiness on face, neck, and upper arm.MedDRA releases: 2024-11 · check-in free text available
-
2022-11-10
Report sent to call center — day 14, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-11-11
Call successfulParticipant prefers to complete VAERS report online
-
2022-11-11
Call successfulParticipant prefers to complete VAERS report online
- 2022-11-17
- 2022-11-24
- 2022-12-01
- 2022-12-08
- 2023-01-29
- 2023-04-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-06 | Pfizer-BioNTech | |
| 2 | 2021-01-27 | Pfizer-BioNTech | |
| 3 | 2022-10-27 | Moderna | No |
Call center
2 call center cases
2 successful
Free text
Release 11 — 12 months, dose 2
Symptoms: Pregnancy
Release 12 — day 14, dose 3
Symptoms: Flare in skin rashes. Redness and itchiness on face, neck, and upper arm.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pre-existing disease | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Rash | · | · | ✓ |
| SD | Rash erythematous | · | · | ✓ |
| SD | Rash pruritic | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release